manidipine and Carcinoma, Ovarian Epithelial
manidipine has been researched along with Carcinoma, Ovarian Epithelial in 2 studies
Carcinoma, Ovarian Epithelial: A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drug resistance in epithelial ovarian cancer (EOC) is reportedly attributed to the existence of cancer stem cells (CSC), because in most cancers, CSCs still remain after chemotherapy." | 1.56 | Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells. ( Choi, DK; Kim, DK; Kim, JH; Kim, JW; Kwon, OB; Lee, DS; Lee, H; Lee, J; Lee, S; Min, SH; Yu, JH, 2020) |
| "Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy in women worldwide, with an overall 5 year survival rate below 30%." | 1.56 | Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness. ( Kim, JW; Lee, DS; Lee, H; Min, SH, 2020) |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lee, H | 2 |
| Kim, JW | 2 |
| Kim, DK | 1 |
| Choi, DK | 1 |
| Lee, S | 1 |
| Yu, JH | 1 |
| Kwon, OB | 1 |
| Lee, J | 1 |
| Lee, DS | 2 |
| Kim, JH | 1 |
| Min, SH | 2 |
Other Studies
2 other studies available for manidipine and Carcinoma, Ovarian Epithelial
| Article | Year |
|---|---|
Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells.
Topics: Animals; Antihypertensive Agents; Apoptosis; Calcium Channel Blockers; Calcium Channels; Carcinoma, | 2020 |
Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness.
Topics: AC133 Antigen; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Ovarian Epithel | 2020 |